Nikhil Prasad Fact checked by:Thailand Medical News Team Sep 19, 2026 40 minutes ago
A fragrant essential oil from the Japanese magnolia Magnolia salicifolia has shown potent anticancer activity against breast cancer cells, while inhalation of its volatile compounds significantly reduced tumor development in mice.
Magnolia salicifolia essential oil and its citral component showed potent breast cancer cell-killing activity and reduced
tumor development in mice
Researchers from the Department of Surgery at Toho University Ohashi Medical Center, Tokyo; the Department of Pharmaceutical Sciences at the International University of Health and Welfare, Narita, Japan; the Aromatic Plant Research Center, Lehi, Utah; and Prime Meridian Healthcare, Pleasant Grove, Utah, conducted the study.
Potent effects against breast cancer cells
The researchers tested M. salicifolia essential oil against 4T1 mouse breast cancer cells and MCF-7 human breast cancer cells. The oil produced strong growth-inhibiting effects, with an IC50—the concentration needed to reduce cell viability by 50%—of 1.05 µg/mL in 4T1 cells and 1.021 µg/mL in MCF-7 cells.
Chemical analysis identified several major components, including 1,8-cineole at 18.50%, geranial at 15.09%, neral at 10.66%, and trans-anethole at 9.99%. Neral and geranial together form citral, which emerged as the oil's principal active anticancer compound.
Citral had an IC50 of 1.93 µg/mL against 4T1 cells, compared with 68.4 µg/mL for 1,8-cineole, making citral substantially more potent. In MCF-7 human cells, citral's IC50 was 1.285 µg/mL.
Inhaled vapor reduced tumors in mice
Perhaps the most notable finding in this
Thailand Medical News report came from the animal experiment. Thirty mice implanted with 4T1 breast cancer cells were divided into two groups. Fifteen were exposed to naturally evaporating M. salicifolia essential oil for eight hours daily, while 15 served as controls.
After four weeks, tumors were detected in 14 of 15 control mice, or 93%, compared with seven of 15 oil-exposed mice, or 47%. The difference was statistically significant. Tumor area and tumor weight were also significantly lower in exposed animals, while body weight was unaffected.
Citral appears to trigger cancer-cell suicide
Mechanistic experiments indicated that citral disrupted mitochondria, the structures responsible for cellular energy production. Researchers observed reduced mitochondrial membrane potential, increased oxidative stress and cytochrome c, increased Bax, reduced anti-apoptotic Bcl-2, and activation of caspase-3 and caspase-9—changes consistent with programmed cell death, or apoptosis.
Importantly, volatile compounds showed preferential toxicity toward cancer cells compared with non-tumorigenic MCF-10A breast epithelial cells. However, the researchers cautioned that the work remains preclinical. The animal mechanism was studied mainly using one murine cancer model, and systemic absorption of inhaled citral was not directly meas
ured.
Conclusion
The findings provide intriguing evidence that M. salicifolia essential oil, particularly its citral component, can suppress breast cancer cells through mitochondrial apoptosis and reduce tumor development in mice. However, additional animal studies, pharmacokinetic research, safety testing, and eventually carefully controlled human studies are needed before inhaled essential oils could be considered an anticancer treatment.
The study findings were published in the peer reviewed journal: Frontiers in Oncology.
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1917503/full
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
Medical Disclaimer: All content published by Thailand Medical News is based on published scientific research and is intended for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Readers must not attempt to use, apply, or experiment with any protocols, compounds, or therapies mentioned without first consulting a qualified and licensed medical doctor. Many findings discussed are experimental or preliminary, and only a licensed healthcare professional can determine what is safe and appropriate for an individual’s specific medical condition. 
Share
Tweet
Share
